Our Science AT-527 COVID-19 About Atea Investors Careers Contact FOUNDER, CHAIRMAN & CEO Jean-Pierre Sommadossi, PhD FULL BIO SENIOR VP, MEDICAL AFFAIRS Claudio Avila, MB, BS, PhD FULL BIO SENIOR VP, INVESTOR RELATIONS & CORPORATE COMMUNICATIONS Jonae Barnes FULL BIO VP, BIOSTATISTICS Bruce Belanger, PhD FULL BIO CFO & EXECUTIVE VP, LEGAL Andrea Corcoran FULL BIO SENIOR VP, HUMAN RESOURCES Paul Fanning FULL BIO SENIOR VP, FINANCE & ADMINISTRATION Wayne Foster FULL BIO EXECUTIVE VP, PRECLINICAL SCIENCE Steven Good FULL BIO CHIEF DEVELOPMENT OFFICER Janet Hammond, MD, PhD FULL BIO CHIEF MEDICAL OFFICER Arantxa Horga, MD FULL BIO VP, CLINICAL OPERATIONS Laura Ishak FULL BIO VP, VIROLOGY Kai Lin, PhD FULL BIO EXECUTIVE VP, CHEMISTRY Adel Moussa, PhD FULL BIO SENIOR VP, CLINICAL SCIENCES Keith Pietropaolo FULL BIO CHIEF COMMERCIAL OFFICER John Vavricka FULL BIO SENIOR VP, REGULATORY AFFAIRS Jayanthi Wolf, PhD FULL BIO EXECUTIVE VP, EARLY STAGE DEVELOPMENT Xiao-Jian Zhou, PhD FULL BIO Board of Directors Jean-Pierre Sommadossi, PhD CHAIRMAN & CEO, ATEA PHARMACEUTICALS Jerome Adams, M.D., M.P.H. FORMER SURGEON GENERAL OF THE UNITED STATES Franklin Berger, CFA FOUNDING & MANAGING DIRECTOR, FMB RESEARCH Barbara Duncan FORMER CFO, INTERCEPT PHARMACEUTICALS Bruno Lucidi LIFE SCIENCES EXPERT, WALLONIA TRADE AND FOREIGN INVESTMENT AGENCY (AWEX) Polly A. Murphy, DVM, PhD CHIEF BUSINESS OFFICER, UROGEN PHARMA Bruce Polsky, MD, MACP, FIDSA PROFESSOR AND CHAIRMAN, DEPARTMENT OF MEDICINE, NYU LANGONE HOSPITAL – LONG ISLAND; ASSOC. DEAN, FACULTY, NYU LONG ISLAND SCHOOL OF MEDICINE Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment. Atea Pharmaceuticals, Inc. 125 Summer Street Boston, MA 02110 (857) 284-8891 Copyright © 2020 By Atea Pharmaceuticals. All Rights Reserved. Privacy Policy | Terms of Use